Delivery Order SPE2DB20D1100-SPE2DB24FD5W7

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery order of TRULICITY 3 MG/0.5 ML PEN 0.5ML, which are pharmaceutical products. The contract has a completion date of July 19, 2024 and is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts by...
This federal contract award, valued at $3,430.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of September 30, 2024 and does not have a set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor in the United States, has been awarded numerous federal contracts to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,193.87, is a delivery order for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has an ultimate completion date of July 30, 2024 and is a firm fixed-price arrangement. Amerisourcebergen, through its Corporate Office division, has been awarded this contract to provide the specified...
This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a delivery order for the pharmaceutical product "TRULICITY 3 MG/0.5 ML PEN 0.5ML" with an ultimate completion date of August 5, 2024. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has been awarded numerous federal contracts and...
This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of August 20, 2024. This award is not associated with a set-aside program. As a large pharmaceutical supplier, Amerisourcebergen has been awarded numerous federal contracts to...
This federal contract award, valued at $4,324.93, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of July 23, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies...
This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a firm-fixed-price delivery order with an ultimate completion date of August 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and indefinite delivery contracts (IDCs) by...
This federal contract award, valued at $7,276.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of September 4, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This federal contract award, valued at $1,161.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of August 15, 2024. Amerisourcebergen, a major supplier of pharmaceutical and medical products to the U.S. government, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $45,947.17 firm-fixed-price delivery order is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of October 15, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD5W7
    Delivery Order

This federal contract award, valued at $3,773.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of September 4, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to supply a wide range of medical commodities, including specialty medications, brand-name and generic drugs, and medical supplies to support military treatment facilities, veterans' hospitals, and other federal healthcare providers. The contract does not have a set-aside designation.

Generated 12/3/24, 10:02 AM